PortfoliosLab logo
HROW vs. META
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between HROW and META is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

HROW vs. META - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Harrow Health, Inc. (HROW) and Meta Platforms, Inc. (META). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

HROW:

1.56

META:

0.70

Sortino Ratio

HROW:

2.76

META:

1.26

Omega Ratio

HROW:

1.33

META:

1.16

Calmar Ratio

HROW:

1.33

META:

0.79

Martin Ratio

HROW:

3.70

META:

2.47

Ulcer Index

HROW:

33.22%

META:

10.93%

Daily Std Dev

HROW:

88.78%

META:

36.15%

Max Drawdown

HROW:

-99.46%

META:

-76.74%

Current Drawdown

HROW:

-82.32%

META:

-19.50%

Fundamentals

Market Cap

HROW:

$895.12M

META:

$1.49T

EPS

HROW:

-$0.49

META:

$25.60

PS Ratio

HROW:

4.48

META:

8.83

PB Ratio

HROW:

12.42

META:

8.11

Total Revenue (TTM)

HROW:

$212.86M

META:

$170.36B

Gross Profit (TTM)

HROW:

$158.64M

META:

$139.27B

EBITDA (TTM)

HROW:

$24.97M

META:

$86.47B

Returns By Period

In the year-to-date period, HROW achieves a -27.27% return, which is significantly lower than META's 1.28% return. Over the past 10 years, HROW has underperformed META with an annualized return of 11.89%, while META has yielded a comparatively higher 22.54% annualized return.


HROW

YTD

-27.27%

1M

3.92%

6M

-53.53%

1Y

110.34%

5Y*

41.21%

10Y*

11.89%

META

YTD

1.28%

1M

8.46%

6M

0.71%

1Y

24.87%

5Y*

22.88%

10Y*

22.54%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

HROW vs. META — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HROW
The Risk-Adjusted Performance Rank of HROW is 8989
Overall Rank
The Sharpe Ratio Rank of HROW is 9292
Sharpe Ratio Rank
The Sortino Ratio Rank of HROW is 9393
Sortino Ratio Rank
The Omega Ratio Rank of HROW is 9090
Omega Ratio Rank
The Calmar Ratio Rank of HROW is 8888
Calmar Ratio Rank
The Martin Ratio Rank of HROW is 8282
Martin Ratio Rank

META
The Risk-Adjusted Performance Rank of META is 7575
Overall Rank
The Sharpe Ratio Rank of META is 7777
Sharpe Ratio Rank
The Sortino Ratio Rank of META is 7272
Sortino Ratio Rank
The Omega Ratio Rank of META is 7171
Omega Ratio Rank
The Calmar Ratio Rank of META is 8080
Calmar Ratio Rank
The Martin Ratio Rank of META is 7676
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

HROW vs. META - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Harrow Health, Inc. (HROW) and Meta Platforms, Inc. (META). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current HROW Sharpe Ratio is 1.56, which is higher than the META Sharpe Ratio of 0.70. The chart below compares the historical Sharpe Ratios of HROW and META, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

HROW vs. META - Dividend Comparison

HROW has not paid dividends to shareholders, while META's dividend yield for the trailing twelve months is around 0.34%.


TTM2024
HROW
Harrow Health, Inc.
0.00%0.00%
META
Meta Platforms, Inc.
0.34%0.34%

Drawdowns

HROW vs. META - Drawdown Comparison

The maximum HROW drawdown since its inception was -99.46%, which is greater than META's maximum drawdown of -76.74%. Use the drawdown chart below to compare losses from any high point for HROW and META. For additional features, visit the drawdowns tool.


Loading data...

Volatility

HROW vs. META - Volatility Comparison

Harrow Health, Inc. (HROW) has a higher volatility of 14.48% compared to Meta Platforms, Inc. (META) at 13.21%. This indicates that HROW's price experiences larger fluctuations and is considered to be riskier than META based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

HROW vs. META - Financials Comparison

This section allows you to compare key financial metrics between Harrow Health, Inc. and Meta Platforms, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00B20.00B30.00B40.00B50.00B20212022202320242025
47.83M
42.31B
(HROW) Total Revenue
(META) Total Revenue
Values in USD except per share items

HROW vs. META - Profitability Comparison

The chart below illustrates the profitability comparison between Harrow Health, Inc. and Meta Platforms, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%65.0%70.0%75.0%80.0%20212022202320242025
67.5%
82.1%
(HROW) Gross Margin
(META) Gross Margin
HROW - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Harrow Health, Inc. reported a gross profit of 32.31M and revenue of 47.83M. Therefore, the gross margin over that period was 67.5%.

META - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Meta Platforms, Inc. reported a gross profit of 34.74B and revenue of 42.31B. Therefore, the gross margin over that period was 82.1%.

HROW - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Harrow Health, Inc. reported an operating income of -11.23M and revenue of 47.83M, resulting in an operating margin of -23.5%.

META - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Meta Platforms, Inc. reported an operating income of 17.56B and revenue of 42.31B, resulting in an operating margin of 41.5%.

HROW - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Harrow Health, Inc. reported a net income of -17.78M and revenue of 47.83M, resulting in a net margin of -37.2%.

META - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Meta Platforms, Inc. reported a net income of 16.64B and revenue of 42.31B, resulting in a net margin of 39.3%.